U.S. Senate negotiators are debating bipartisan legislation that would require AI developers to demonstrate they are taking reasonable precautions to prevent harm.
The proposed duty of care would empower the U.S. commerce secretary to request evidence and deploy government auditors to test products.
President Donald Trump expressed opposition to new rules, stating that existing authorities are already adequate to regulate technology companies.